{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:51:47Z","timestamp":1790095907616,"version":"4.0.1"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,14]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Orofacial granulomatosis [OFG] is a rare syndrome that may be associated with Crohn\u2019s disease [CD]. We aimed to characterise this relationship and the management options in the biologic era.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This multicentre case series was supported by the European Crohn\u2019s and Colitis Organisation [ECCO], and performed as part of the Collaborative Network of Exceptionally Rare case reports [CONFER] project. Clinical data were recorded in a standardised collection form.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>This report includes 28 patients with OFG associated with CD: 14 males (mean age of 32 years, \u00b112.4 standard deviation [SD]) and 14 females [40.3 years, \u00b121.0 SD]. Non-oral upper gastrointestinal tract involvement was seen in six cases and perianal disease in 11. The diagnosis of OFG was made before CD diagnosis in two patients, concurrently in eight, and after CD diagnosis in 18. The distribution of OFG involved the lips in 16 cases and buccal mucosa in 18. Pain was present in 25 cases, with impaired swallowing or speaking in six. Remission was achieved in 23 patients, notably with the use of anti-tumour necrosis factors [TNFs] in nine patients, vedolizumab in one, ustekinumab in one, and thalidomide in two. A further five cases were resistant to therapies including anti-TNFs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>OFG associated with CD may occur before, concurrently with, or after the diagnosis of CD. Perianal and upper gastrointestinal [UGI] disease are common associations and there is a significant symptom burden in many. Remission can be obtained with a variety of immunosuppressive treatments, including several biologics approved for CD.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ecco-jcc\/jjab158","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T11:46:29Z","timestamp":1631101589000},"page":"430-435","source":"Crossref","is-referenced-by-count":18,"title":["Orofacial Granulomatosis Associated with Crohn\u2019s Disease: a Multicentre Case Series"],"prefix":"10.1093","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1671-2390","authenticated-orcid":false,"given":"Frank","family":"Phillips","sequence":"first","affiliation":[{"name":"NIHR Nottingham Digestive Diseases Biomedical Research Centre, Nottingham University Hospitals, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3898-7093","authenticated-orcid":false,"given":"Bram","family":"Verstockt","sequence":"additional","affiliation":[{"name":"University Hospitals Leuven, Gastroenterology and Hepatology, KU Leuven, Chronic Diseases, Metabolism and Ageing, TARGID-IBD unit, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Sladek","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Gastroenterology and Nutrition, Jagiellonian University Medical College, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanne","family":"de Boer","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, Department of Gastroenterology and Hepatology, Amsterdam UMC, Vrije Universiteit Amsterdam, AGEM Research Institute, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Katsanos","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Ioannina School of Health Sciences, Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Karmiris","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Venizeleio General Hospital, Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8962-4263","authenticated-orcid":false,"given":"Ahmad","family":"Albshesh","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sheba Medical Centre, Tel Hashomer, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1046-383X","authenticated-orcid":false,"given":"Carl","family":"Erikson","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine and Health, \u00d6rebro University, \u00d6rebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bergemalm","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine and Health, \u00d6rebro University, \u00d6rebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Molnar","sequence":"additional","affiliation":[{"name":"First Department of Medicine, University of Szeged, Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Ellul","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, Mater Dei hospital, Msida, Malta"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,9,8]]},"reference":[{"key":"2022031414222627400_CIT0001","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ajg.2010.343","article-title":"Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort","volume":"106","author":"Vavricka","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"2022031414222627400_CIT0002","first-page":"101","article-title":"Oro-facial granulomatosis \u2013 a clinical and pathological analysis","volume":"54","author":"Wiesenfeld","year":"1985","journal-title":"Q J Med"},{"key":"2022031414222627400_CIT0003","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1365-2036.2004.02205.x","article-title":"Review article: orofacial granulomatosis","volume":"20","author":"Le\u00e3o","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"2022031414222627400_CIT0004","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/ibd.21599","article-title":"Distinguishing orofacial granulomatosis from Crohn\u2019s disease: two separate disease entities?","volume":"17","author":"Campbell","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"2022031414222627400_CIT0005","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/DAD.0000000000000343","article-title":"Histopathological features of orofacial granulomatosis","volume":"38","author":"Marcoval","year":"2016","journal-title":"Am J Dermatopathol"},{"key":"2022031414222627400_CIT0006","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1601-0825.2008.01500.x","article-title":"Orofacial granulomatosis \u2013 a 20-year review","volume":"15","author":"Grave","year":"2009","journal-title":"Oral Dis"},{"key":"2022031414222627400_CIT0007","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.crohns.2011.07.001","article-title":"Oral Crohn\u2019s disease: is it a separable disease from orofacial granulomatosis? A review","volume":"6","author":"Zbar","year":"2012","journal-title":"J Crohns Colitis"},{"key":"2022031414222627400_CIT0008","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/01.MIB.0000178261.88356.67","article-title":"Oro-facial granulomatosis: Crohn\u2019s disease or a new inflammatory bowel disease?","volume":"11","author":"Sanderson","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"2022031414222627400_CIT0009","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1046\/j.1365-2133.2000.03877.x","article-title":"Human leucocyte antigen typing in orofacial granulomatosis","volume":"143","author":"Gibson","year":"2000","journal-title":"Br J Dermatol"},{"key":"2022031414222627400_CIT0010","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1097\/MIB.0000000000000844","article-title":"Genetic association analysis reveals differences in the contribution of NOD2 variants to the clinical phenotypes of orofacial granulomatosis","volume":"22","author":"Mentzer","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2022031414222627400_CIT0011","doi-asserted-by":"crossref","first-page":"e584","DOI":"10.4317\/medoral.20187","article-title":"Immunophenotype in orofacial granulomatosis with and without Crohn\u2019s disease","volume":"19","author":"Gale","year":"2014","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"2022031414222627400_CIT0012","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/jop.12379","article-title":"Azathioprine is effective for oral involvement in Crohn\u2019s disease but not for orofacial granulomatosis alone","volume":"45","author":"Mentzer","year":"2016","journal-title":"J Oral Pathol Med"},{"key":"2022031414222627400_CIT0013","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0714.2010.00976.x","article-title":"Experience with anti-TNF-\u03b1 therapy for orofacial granulomatosis","volume":"40","author":"Elliott","year":"2011","journal-title":"J Oral Pathol Med"},{"key":"2022031414222627400_CIT0014","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/archderm.135.4.439","article-title":"Oral Crohn disease: clinical characteristics and long-term follow-up of 9 cases","volume":"135","author":"Dupuy","year":"1999","journal-title":"Arch Dermatol"},{"key":"2022031414222627400_CIT0015","first-page":"1467","article-title":"Clinical aspects of Crohn\u2019s disease of the upper gastrointestinal tract: a comparison with distal Crohn\u2019s disease","volume":"92","author":"Wagtmans","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"2022031414222627400_CIT0016","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S1542-3565(05)00424-6","article-title":"A prospective study of the oral manifestations of Crohn\u2019s disease","volume":"3","author":"Harty","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022031414222627400_CIT0017","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/prd.12264","article-title":"The mouth in inflammatory bowel disease and aspects of orofacial granulomatosis","volume":"80","author":"Hullah","year":"2019","journal-title":"Periodontol 2000"},{"key":"2022031414222627400_CIT0018","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1111\/j.1572-0241.2008.02094_16.x","article-title":"Oral Crohn\u2019s disease: a favorable clinical response with delayed-release triamcinolone acetonide intralesional injections","volume":"103","author":"Mignogna","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"2022031414222627400_CIT0019","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/01.MIB.0000215096.51943.82","article-title":"Successful infliximab therapy for oral Crohn\u2019s disease","volume":"12","author":"Cardoso","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"2022031414222627400_CIT0020","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1067\/moe.2002.113","article-title":"Thalidomide for the treatment of recalcitrant oral Crohn\u2019s disease and orofacial granulomatosis","volume":"95","author":"Hegarty","year":"2003","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"2022031414222627400_CIT0021","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/qjmed\/93.8.507","article-title":"The role of allergy in oral mucosal diseases","volume":"93","author":"Wray","year":"2000","journal-title":"QJM"},{"key":"2022031414222627400_CIT0022","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/00054725-200606000-00011","article-title":"Improvement in orofacial granulomatosis on a cinnamon- and benzoate-free diet","volume":"12","author":"White","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"2022031414222627400_CIT0023","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1093\/ibd\/izaa123","article-title":"Using ustekinumab to treat Crohn\u2019s disease-related orofacial granulomatosis: two birds, one stone","volume":"26","author":"Gilmore","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"2022031414222627400_CIT0024","doi-asserted-by":"crossref","first-page":"1756284820934327","DOI":"10.1177\/1756284820934327","article-title":"Recurrent granulomatous cheilitis associated with Crohn\u2019s disease successfully treated with ustekinumab: case report and literature review","volume":"13","author":"Taxonera","year":"2020","journal-title":"Therap Adv Gastroenterol"},{"key":"2022031414222627400_CIT0025","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/ecco-jcc\/jjaa078","article-title":"Inflammatory cutaneous lesions in inflammatory bowel disease treated with vedolizumab or ustekinumab: an ECCO CONFER multicentre case series","volume":"14","author":"Phillips","year":"2020","journal-title":"J Crohns Colitis"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/advance-article-pdf\/doi\/10.1093\/ecco-jcc\/jjab158\/40513045\/jjab158.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/16\/3\/430\/42893761\/jjab158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/16\/3\/430\/42893761\/jjab158.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T20:57:45Z","timestamp":1673211465000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/16\/3\/430\/6366377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,8]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,9,8]]},"published-print":{"date-parts":[[2022,3,14]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab158","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3,1]]},"published":{"date-parts":[[2021,9,8]]}}}